Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study

Authors

Institutions

Publication Details

Journal
EClinicalMedicine
Published
2025-03-18
DOI
https://doi.org/10.1016/j.eclinm.2025.103160
Citations
11
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
14.38
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study

Zijun Zhu, Chaoyong Zhu, Dengfeng Ren, Jiuda Zhao et al.
11 citations
EClinicalMedicine
Pharmacovigilance and Adverse Drug Reactions
14.38
article

Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study

Zijun Zhu, Chaoyong Zhu, Dengfeng Ren, Jiuda Zhao, Zhilin Liu, Yongxin Li, Yixiao Zhang, Fuxing Zhao, Qiuxia Dong
article en
11 citations

Abstract

No abstract available for this paper.
EClinicalMedicineVol. 82
Qinghai University Affiliated Hospital (CN), Qinghai Red Cross Hospital (CN)
Good health and well-being
Openalex Percentile: Top 1%
Pharmacovigilance and Adverse Drug Reactions
14.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.